Mitral transcatheter edge-to-edge repair (TEER) using the latest, fourth-generation MitraClip system (Abbott Vascular) provides significant mitral regurgitation (MR) reduction and quality of life (QoL) improvement in patients previously deemed unsuitable for the procedure.